Pharma 

Regularly advise pharma companies in their compliances under the D&C Act and DPCO, 2013.

Regularly collaborate with international firms to advise clients on clinical trial regulations in India, regulations concerning new drug approvals, regulations concerning conduct of bio-availability studies in India and like issues arising out of regulatory framework in India.

Advised and represented the IDMA (Indian Drug Manufacturers’ Association) and FOPE (Foundation of Pharma Entrepreneurs) before the Hon’ble High Court and Hon’ble Supreme Court in a matter pertaining to “Product Approval” for Food Business Operators (FBOs). The resultant order passed by the Hon’ble Supreme Court in this matter has led to the Product Approval Advisories being set to naught.

Successfully represented IDMA (Indian Drug Manufacturers’ Association) and FOPE (Foundation of Pharma Entrepreneurs) for the entire industry before the Hon’ble Delhi High Court and Hon’ble Supreme Court in challenging the order of the Central Government by which it had banned 344 fixed dose combinations drugs overnight .

Advised and represented a domestic pharmaceutical company and one of its shareholders in shareholder disputes and other disputes arising from such shareholder disputes, including but not limited to disputes with lenders, before the Delhi High Court, Company Law Board, Debt Recovery Tribunal and constituted Arbitral Tribunal.